Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

STEP 6

Novo Nordisk · Phase 3 · Completed · Enrollment 401

NCT03811574

ArmPopulationDoseWeeksEstimandWeight change
Semaglutide 2.4 mgObesity or overweight2.4 mg68ITTn/r
Placebo (semaglutide 2.4 mg)Obesity or overweight2.4 mg68ITTn/r
Semaglutide 1.7 mgObesity or overweight1.7 mg68ITTn/r
Placebo (semaglutide 1.7 mg)Obesity or overweight1.7 mg68n/rn/r